PRGS · Progress Software Corporation

The thesis

Progress Software's Domo purchase lifted its fiscal 2026 revenue outlook, but the weaker fourth-quarter earnings guide and the revolver-funded debt leave the case unproven; the fiscal fourth-quarter report, which Unusual Whales lists for about 19 January 2027 (unconfirmed), settles whether the added revenue becomes the profit management projects. The shares closed at $44.46 on 28 October 2026, with no new company filing or announcement in the 13 days since the previous note.

Split- and dividend-adjusted daily closes put the shares at $36.90 on 2 October 2026, $40.87 on 15 October 2026 and $44.46 on 28 October 2026. The 52-week high is $46.45, 4.3% above the latest close, and the 14-day relative strength index (RSI), a momentum gauge where readings above 70 mark a stretched run, stands at 74.7. The three-month price change is 9.5%.

The narrative is maturing: the story is well known, the Domo deal closed on 22 September 2026, and the next company-specific test is more than eleven weeks away. The shares have recovered the full post-report drop without any change to the fourth-quarter guide that caused it.

Bullish and bearish views on Progress Software Corporation

The bull case on Progress Software Corporation (PRGS), in brief: Revenue outlook rose sharply. The bear case: Fourth-quarter earnings guide missed.

Bull case

• Revenue outlook rose sharply. Progress raised fiscal 2026 revenue guidance to $1.044 billion-$1.052 billion on 30 September 2026, from $990.0 million-$1.002 billion on 30 June 2026. Fourth-quarter revenue is guided to $297 million-$305 million (company release).
• Fiscal 2026 adjusted EPS guidance is $6.15-$6.23.
• Cash generation is growing. Adjusted free cash flow was $87.161 million in the third quarter, up 17% year on year. Fiscal 2026 is guided to $275 million-$283 million (company release, 30 September 2026).
• Domo economics are quantified. Management said Domo should add well over $100 million of annual EBITDA (earnings before interest, taxes, depreciation and amortization) by the end of fiscal 2027, on steady-state revenue of $280 million-$290 million (Investing.com summary of the 30 September 2026 call).
• Analyst targets sit above the price. DA Davidson reiterated Buy with a $55 target on 2 October 2026 (Investing.com). Oppenheimer kept Outperform with a $50 target on 1 July 2026 (Benzinga).

Bear case

• Fourth-quarter earnings guide missed. Adjusted EPS is guided to $1.24-$1.33 against a $1.43 consensus, and GAAP EPS (generally accepted accounting principles) to a loss of $0.41 to $0.32 (Benzinga, 30 September 2026).
• Reported earnings were cut again. Fiscal 2026 GAAP EPS guidance fell to $1.18-$1.28 from $1.60-$1.74 (company release, 30 September 2026).
• Organic growth is flat to down. Third-quarter revenue was $246.005 million, down 2% year on year, below the $247.325 million consensus. Annualized recurring revenue was $873 million, up 1% in constant currency.
• Debt funds the deal. At 31 August 2026, before the Domo draw, long-term debt was $790 million, convertible notes $442.635 million and cash $113.7 million (10-Q). Management expects Domo to cut fiscal 2027 operating margin by 100 to 200 basis points.
• Momentum is stretched. An RSI of 74.7 on 28 October 2026 and a close within 4.3% of the 52-week high mean the shares now price in much of the recovery before any fourth-quarter evidence.

Price setup

The close of $44.46 on 28 October 2026 sits $7.56 above the post-report low close of $36.90 (2 October 2026) and $1.99 below the 52-week high of $46.45. The close on 30 September 2026, the day of the report, was $39.97 (Investing.com). The shares are therefore well above the pre-report level.

A close above $46.45 would be a new 52-week high. A close below $39.97 would erase the whole rebound and return the shares to where they traded before the guidance miss.

Crowding evidence is limited to price: the RSI reading of 74.7 and the narrow gap to the high. No SEC Form 4 insider sales or share issuance have been reported since the previous note, and the next earnings report falls outside the next 30 days.

Catalysts, next 30 days

• No company-scheduled event falls inside the next 30 days. Third-party earnings calendars disagree on the fourth-quarter report date: Earnings Whispers shows both 30 December 2026 and a November 2026 listing, while Unusual Whales lists about 19 January 2027.
• 30 November 2026: fiscal year 2026 ends, closing the first period that includes Domo.
• ~19 January 2027 (est.): fiscal fourth-quarter and full-year 2026 results, testing the $1.24-$1.33 adjusted EPS guide and the $297 million-$305 million revenue guide.

What would change the view

The case breaks if fiscal fourth-quarter adjusted EPS lands below the $1.24-$1.33 guide, if fourth-quarter revenue falls short of $297 million-$305 million, or if management cuts the $280 million-$290 million Domo revenue outlook. A further GAAP EPS cut below $1.18-$1.28 for fiscal 2026 would show acquisition costs widening faster than guided.

On price, a daily close below $39.97, the 30 September 2026 close before the report, would show the rebound has failed. The case would strengthen if the report shows net debt falling from the post-closing level and annualized recurring revenue growth above the 1% constant-currency rate reported on 30 September 2026.

What it trades with

Progress trades as an acquisitive, low-growth infrastructure software company rather than as an artificial intelligence beneficiary. Its closest comparisons are other mid-cap software companies that grow by purchase and carry convertible debt. Domo shares rose over 23% after hours on 22 July 2026 on the $400 million asset sale, but the Domo shell no longer drives Progress's price. Software-sector multiples and interest-rate moves are the main outside forces on the stock.